Is 4Basebio PLC halal to invest in?

According to Musaffa's Shariah screening methodology, 4Basebio PLC (4BB.L) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is 4Basebio PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes 4Basebio PLC using these criteria to determine its compliance status.

Can Muslims buy shares of 4Basebio PLC?

Muslim investors may consider investing in 4Basebio PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is 4Basebio PLC classified as NOT HALAL?

Musaffa determines the Shariah status of 4Basebio PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for 4Basebio PLC updated?

The Shariah compliance status of 4Basebio PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like 4Basebio PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of 4Basebio PLC?

You can check the latest Shariah compliance status of 4Basebio PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

4Basebio PLC 4BB.L

GBX435.13

Last Updated: May 15, 12:00 AM·LSE

4BB.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 08, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for 4Basebio PLC (4BB.L)

Based on 9 analysts giving stock ratings to 4Basebio PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

4Basebio PLC. Stock Analysis 4BB.L

United Kingdom Health Care Micro Cap Report: Q2, 2025

4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is focused on the development of advanced therapy medicinal products (ATMPs) through its synthetic Deoxyribonucleic acid (DNA) products and non-viral, cell-targeting nucleic acid delivery platform. The firm offers application-specific DNA constructs tailored to the diverse needs of gene therapies, genome editing, mRNA production, and DNA vaccines. Its synthetic DNA is produced via an enzymatic, cell-free manufacturing process. The company utilizes a technology for primer-free DNA amplification called TruePrime, which enables high-yield and quality DNA production. By combining two enzymes, Trueprime technology achieves isothermal multiple displacement DNA amplification in a continuous cell-free process with high fidelity. The firm offers application-specific synthetic DNA solutions across mRNA vaccines and therapies, viral vectors, gene editing, DNA vaccines and non-viral delivery.

Key Statistics of 4Basebio PLC (4BB.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX435.00GBX435.13

Today's Open

GBX435.13

Volume

6.00

P/E Ratio (TTM)

52 Week Range

GBX420.00GBX1,150.00

Market Cap

7.82B

Avg. Volume

872.55

Dividend Yield

Financial Metrics & Statements of 4Basebio PLC (4BB.L)

FAQ's for 4Basebio PLC (4BB.L)

According to Musaffa’s Shariah screening methodology, 4Basebio PLC (4BB.L) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.